ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
- ESMO 2024
- WCLC 2024
- 2nd Annual BMC Chhattisgarh Cancer Conclave & 5th Choosing Wisely 2024
- TMC Kolkata Psycho-Oncology Congress
- ESMO GI 2024
- Best of ASCO® 2024 Miami Symposium
- ASCO® 2024
- EHA 2024
- ELCC 2024
- EAU 2024
- ASCO GU 2024
- ASCO GI 2024
- 2023
- 2022 and 2021
- Common Sense Oncology
- Lymphoma
- Leukemia
- Myeloma
- GYN Cancers
- Head&Neck Cancers
- GI Cancers
- Breast Cancers
- GU Cancers
- Lung Cancers
- Skin Cancers
- Basic Science
- Supportive & Palliative Care
- Business
- Events
Playback speed
10 seconds
ESMO 2024 Summary: EGFRm NSCLC Panel Discussion - MARIPOSA, PAPILLON, REZILIENT1, LAURA, and SKIPPirr
218 views
October 11, 2024
Chapters
LAURA Trial Data for Stage III & CNS Progression
00:00
MARIPOSA Trial Updates & Combating CNS Progression
04:29
Resistance Mechanisms in MARIPOSA & SKIPPER Trial
07:18
PAPILLON & RESILIENT Trials for Exon 20 Insertions
10:36
Immunotherapy Approaches in EGFR-Mutant Population
13:59
Key Takeaways from ESMO 2024 on EGFR-mutant NSCLC
15:47
Comments 0
Login to view comments.
Click here to Login
ESMO 2024